News

čeština/english

A decision of the Ministry of Health of the CR under the no. MZDR 44231/2021-2/OLZP

MZCR 11. 01. 2022

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant HRA Pharma Rare Diseases, against the decision of the State Institute for Drug Control from 14. 10. 2021, under the no: SUKLS34108/2021:

  • the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

Back to news listing